EXACT Therapeutics AS Sustainability Reports

EXACT Therapeutics AS is a clinical-stage biopharmaceutical company focused on developing its Acoustic Cluster Therapy (ACT®) platform. This technology uses ultrasound-mediated microbubbles to enhance the targeted delivery of therapeutic agents for conditions like oncology.

Sector: Professional & technical services

Country: Norway

Exchange: Oslo Børs

LEI: 2138006ZE5JAL39AGD55

FIGI: BBG00W0H5K29

6 reports from 2020 to 2025

• EXACT Therapeutics AS 2025 Annual Report
• EXACT Therapeutics AS 2024 Annual Report
• EXACT Therapeutics AS 2023 Annual Report
• EXACT Therapeutics AS 2022 Annual Report
• EXACT Therapeutics AS 2021 Annual Report